Digital twins are virtual replicas of physical bioprocess systems that integrate real-time sensor data, mechanistic models, and machine learning to simulate process behavior. Their relevance to industrial-scale bioprocess development lies in enabling rapid scale-up, predictive control, and root-cause analysis without risking batches or disrupting production. Michael Grieves Florida Institute of Technology introduced the digital twin concept and framed its lifecycle value for manufacturing, giving manufacturers a conceptual foundation for applying twins to bioprocessing. Fei Tao Huazhong University of Science and Technology has further formalized architectures that link physical assets, virtual models, and data flows, demonstrating how closed-loop optimization can operate at industrial scale.
How digital twins improve process understanding and control
Digital twins combine mechanistic models of cell growth, substrate consumption, and product formation with data-driven models trained on historical runs. This hybrid approach reduces uncertainty during scale transitions because mechanistic elements preserve known biology while machine learning captures systematic deviations observed in production. Inline sensors and process analytical technology feed the twin so it can run virtual experiments and support model predictive control. That means operators can test parameter changes in silico to forecast yields, impurity profiles, and risk of failure before implementing changes on the factory floor.
Operational, regulatory, and environmental consequences
Operationally, digital twins shorten development cycles and lower costs by enabling fewer physical experiments during scale-up and enabling earlier detection of excursions. For regulators and quality systems, validated twins can provide traceable decision-support that aligns with quality-by-design principles, improving compliance while reducing batch recalls. Environmentally, optimized recipes and tighter control decrease raw-material consumption, energy use, and waste generation, which is especially meaningful in resource-intensive biologics manufacture. Cultural and territorial nuances matter: facilities in regions with strong digital infrastructure and data governance adoption realize benefits faster, while sites with limited connectivity or workforce digital skills require phased implementation and targeted training. Adoption therefore depends as much on organizational readiness and regulatory dialogue as on technical performance.
Challenges remain, including data integrity, model validation, and workforce reskilling. Addressing these challenges through cross-disciplinary teams of bioprocess engineers, data scientists, and regulators makes digital twins a practical path to safer, more efficient, and more sustainable industrial bioprocess development.